{"title":"丙型肝炎:诊断、治疗和减少危害策略","authors":"G. Parsons","doi":"10.1002/psb.2001","DOIUrl":null,"url":null,"abstract":"The introduction of new and effective direct‐acting antivirals has revolutionised the treatment of hepatitis C over the last decade. Part 2 of this two‐part series on the management of hepatitis C provides an overview of these new treatments, as well as discussing hepatitis C diagnosis and harm‐reduction strategies.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"40 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hepatitis C: diagnosis, treatment and harm‐reduction strategies\",\"authors\":\"G. Parsons\",\"doi\":\"10.1002/psb.2001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The introduction of new and effective direct‐acting antivirals has revolutionised the treatment of hepatitis C over the last decade. Part 2 of this two‐part series on the management of hepatitis C provides an overview of these new treatments, as well as discussing hepatitis C diagnosis and harm‐reduction strategies.\",\"PeriodicalId\":88184,\"journal\":{\"name\":\"The Prescriber\",\"volume\":\"40 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Prescriber\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/psb.2001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/psb.2001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Hepatitis C: diagnosis, treatment and harm‐reduction strategies
The introduction of new and effective direct‐acting antivirals has revolutionised the treatment of hepatitis C over the last decade. Part 2 of this two‐part series on the management of hepatitis C provides an overview of these new treatments, as well as discussing hepatitis C diagnosis and harm‐reduction strategies.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
